期刊
NATURE MEDICINE
卷 20, 期 10, 页码 1182-1186出版社
NATURE PORTFOLIO
DOI: 10.1038/nm.3656
关键词
-
资金
- US National Institutes of Health (NIH) [P30 AR061303, R03 AR063328]
- Sanford-Burnham Center
- California Institute for Regenerative Medicine (CIRM) Training grant [TG2 001162]
- Italian Foreign Ministry (MAE)
- NIH [P30 AR061303, R01AR056712, R01AR052779]
- Fondazione Telethon Funding Source: Custom
The progressive loss of muscle regenerative capacity with age or disease results in part from a decline in the number and function of satellite cells, the direct cellular contributors to muscle repair(1-11). However, little is known about the molecular effectors underlying satellite cell impairment and depletion. Elevated levels of inflammatory cytokines, including interleukin-6 (IL-6), are associated with both age-related and muscle-wasting conditions(12-15). The levels of STAT3, a downstream effector of IL-6, are also elevated with muscle wasting(16,17), and STAT3 has been implicated in the regulation of self-renewal and stem cell fate in several tissues18-21. Here we show that IL-6-activated Stat3 signaling regulates satellite cell behavior, promoting myogenic lineage progression through myogenic differentiation 1 (Myod1) regulation. Conditional ablation of Stat3 in Pax7-expressing satellite cells resulted in their increased expansion during regeneration, but compromised myogenic differentiation prevented the contribution of these cells to regenerating myofibers. In contrast, transient Stat3 inhibition promoted satellite cell expansion and enhanced tissue repair in both aged and dystrophic muscle. The effects of STAT3 inhibition on cell fate and proliferation were conserved in human myoblasts. The results of this study indicate that pharmacological manipulation of STAT3 activity can be used to counteract the functional exhaustion of satellite cells in pathological conditions, thereby maintaining the endogenous regenerative response and ameliorating muscle-wasting diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据